25 results
424B5
IGMS
IGM Biosciences Inc
23 Jun 23
Prospectus supplement for primary offering
4:35pm
common stock as a position in a hedging transaction, “straddle,” “conversion transaction” or other risk reduction transaction;
persons who hold
424B5
IGMS
IGM Biosciences Inc
22 Jun 23
Prospectus supplement for primary offering
6:19am
or long-term residents of the United States;
persons who hold our common stock as a position in a hedging transaction, “straddle,” “conversion
424B3
1vf i52362kmx705g
8 Aug 22
Prospectus supplement
5:06pm
424B5
k1wpzv9d gg6q94
30 Mar 22
Prospectus supplement for primary offering
5:09pm
424B5
dvia bb3cr
29 Mar 22
Prospectus supplement for primary offering
7:36am
424B5
xno6fwsj7y
9 Dec 20
Prospectus supplement for primary offering
5:24pm
424B5
76necanwh
7 Dec 20
Prospectus supplement for primary offering
5:28pm
S-3
hti n54e5
5 Nov 20
Shelf registration
7:47am
8-K
EX-3.1
pyvn 7jyqqi8lbz281pr
12 Jun 20
Amendments to Articles of Incorporation or Bylaws
5:11pm
8-K
EX-3.2
zisn3l2
20 Sep 19
IGM Biosciences Announces Closing of Initial Public Offering, Including Full
5:27pm
424B4
1fl63goc1 ta8
18 Sep 19
Prospectus supplement with pricing info
4:43pm